KAT2B, EP300, KAT6A (MYST family), and KAT2A (GNAT family) are recruited to ER-responsive promoters and are critical for estrogen-dependent proliferation of ER-positive breast cancer cells [22–24]. Here, EP300 is linked to breast carcinoma.